Why the study?
Prolonged hypothyroidism is known to reduce myocardial contractility, but its direct role in the development of dilated cardiomyopathy with heart failure remains a matter of debate.
Does L-thyroxine and guideline-directed medical therapy improve cardiac function in a patient with dilated cardiomyopathy attributed to severe hypothyroidism?
Case Report (n=1)
Does L-thyroxine and guideline-directed medical therapy improve cardiac function in a patient with dilated cardiomyopathy attributed to severe hypothyroidism?
Answers are grounded in this paper and cite their sources.
Severe dilated cardiomyopathy can be a reversible consequence of profound hypothyroidism, highlighting the importance of routine thyroid function screening in new-onset heart failure.
Dilated cardiomyopathies generally carry a poor prognosis due to progressive and often irreversible myocardial dysfunction. In rare cases, a metabolic etiology may be identified, allowing for significant improvement in cardiac function with appropriate treatment. Prolonged hypothyroidism is known to reduce myocardial contractility; however, its direct role in the development of dilated cardiomyopathy with heart failure remains a matter of debate. We report the case of a patient with severe peripheral hypothyroidism associated with dilated cardiomyopathy and global heart failure. Hormone replacement therapy leading to the restoration of euthyroidism resulted in marked improvement of cardiac function. This case highlights the importance of screening for hypothyroidism in all patients presenting with dilated cardiomyopathy of unknown etiology.
No takes yet. Share an insight, caveat, or question.
Sani et al. (2025) conducted a case report in Dilated cardiomyopathy and hypothyroidism (n=1). L-thyroxine was evaluated on Left ventricular ejection fraction (LVEF).
Synapse has enriched 10 related papers. Consider them for comparative context: